Angelman Syndrome Clinical Trials Angelman Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
Condition:   Angelman Syndrome Intervention:   Drug: Gaboxadol Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2019 Category: Research Source Type: clinical trials